The ABC Transporters: Structural Insights into Drug Transport

[1]  M. Cairo,et al.  Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors. , 1989, Cancer research.

[2]  M. Melamed,et al.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  K. Locher,et al.  Structure of an ABC transporter in complex with its binding protein , 2007, Nature.

[4]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[5]  I. Pastan,et al.  Fluorescent cellular indicators are extruded by the multidrug resistance protein. , 1993, The Journal of biological chemistry.

[6]  J. Riordan,et al.  ATP Binding to the First Nucleotide-binding Domain of Multidrug Resistance Protein MRP1 Increases Binding and Hydrolysis of ATP and Trapping of ADP at the Second Domain* , 2002, The Journal of Biological Chemistry.

[7]  J. Wijnholds,et al.  The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy. , 2004, Antiviral Research.

[8]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[9]  Sergio Marco,et al.  Three-dimensional Reconstruction of the Saccharomyces cerevisiae Multidrug Resistance Protein Pdr5p* , 2003, The Journal of Biological Chemistry.

[10]  K. Ueda,et al.  Amino acid substitutions in the first transmembrane domain (TM1) of P‐glycoprotein that alter substrate specificity , 1997, FEBS letters.

[11]  A. Holzenburg,et al.  The Structure of the Multidrug Resistance Protein 1 (MRP1/ABCC1) , 2001, The Journal of Biological Chemistry.

[12]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[13]  A. E. Senior,et al.  Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein. , 2000, Biochemistry.

[14]  The nucleotide-binding domains of P-glycoprotein. Functional symmetry in the isolated domain demonstrated by N-ethylmaleimide labelling. , 2003, European journal of biochemistry.

[15]  A. E. Senior,et al.  ATP hydrolysis by multidrug-resistance protein from Chinese hamster ovary cells , 1995, Journal of bioenergetics and biomembranes.

[16]  J. Riordan,et al.  Allosteric Interactions between the Two Non-equivalent Nucleotide Binding Domains of Multidrug Resistance Protein MRP1* , 2000, The Journal of Biological Chemistry.

[17]  K. Diederichs,et al.  Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis , 2000, The EMBO journal.

[18]  D. Hutchison,et al.  CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY. , 1963, Advances in cancer research.

[19]  D. Allaway,et al.  Solute‐binding protein‐dependent ABC transporters are responsible for solute efflux in addition to solute uptake , 2001, Molecular microbiology.

[20]  I. Pastan,et al.  In situ Localization of the Human Multidrug‐resistance Gene mRNA Using Thymine‐Thymine Dimerized Single‐stranded cDNA , 1990, Japanese journal of cancer research : Gann.

[21]  T. Tsuruo,et al.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.

[22]  P. Borst,et al.  Multidrug resistance mediated by P-glycoproteins. , 1991, Seminars in cancer biology.

[23]  P. Charlton,et al.  Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. , 1999, Bioorganic & medicinal chemistry letters.

[24]  William Saurin,et al.  Getting In or Out: Early Segregation Between Importers and Exporters in the Evolution of ATP-Binding Cassette (ABC) Transporters , 1999, Journal of Molecular Evolution.

[25]  A. Seelig,et al.  Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  C. Higgins,et al.  The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein. , 2001, Biochemistry.

[27]  J. L. Biedler,et al.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. , 1970, Cancer research.

[28]  R. Callaghan,et al.  The coupling mechanism of P‐glycoprotein involves residue L339 in the sixth membrane spanning segment , 2005, FEBS letters.

[29]  M. Raida,et al.  Localization of the Iodomycin Binding Site in Hamster P-glycoprotein* , 1997, The Journal of Biological Chemistry.

[30]  Roman Rouzier,et al.  Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma , 2005, Cancer.

[31]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[32]  R. Neubig,et al.  Walker A Lysine Mutations of TAP1 and TAP2 Interfere with Peptide Translocation but Not Peptide Binding* , 2001, The Journal of Biological Chemistry.

[33]  D. Kerr,et al.  Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. , 1994, European journal of pharmacology.

[34]  A. Walmsley,et al.  Structure and function of efflux pumps that confer resistance to drugs. , 2003, The Biochemical journal.

[35]  M. Putman,et al.  Multidrug resistance in lactic acid bacteria: molecular mechanisms and clinical relevance , 1999, Antonie van Leeuwenhoek.

[36]  T. Tsuruo,et al.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. , 1988, Cancer research.

[37]  I. Roninson,et al.  Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein. , 2001, Biochemistry.

[38]  J. Löwe,et al.  Crystal structure of the SMC head domain: an ABC ATPase with 900 residues antiparallel coiled-coil inserted. , 2001, Journal of molecular biology.

[39]  T. Tsuruo,et al.  Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. , 1984, Cancer research.

[40]  J. Hunt,et al.  Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. , 2001, Structure.

[41]  I. Pastan,et al.  Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.

[42]  D. Clarke,et al.  Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. , 2006, The Biochemical journal.

[43]  V. Ling,et al.  Reconstitution of Drug Transport by Purified P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[44]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.

[45]  P. Gros,et al.  Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3. , 1995, Biochemistry.

[46]  K. Linton,et al.  Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.

[47]  Z. Sauna,et al.  The A‐loop, a novel conserved aromatic acid subdomain upstream of the Walker A motif in ABC transporters, is critical for ATP binding , 2006, FEBS letters.

[48]  Y. Yuan,et al.  The Crystal Structure of the MJ0796 ATP-binding Cassette , 2001, The Journal of Biological Chemistry.

[49]  K. Linton,et al.  The Topography of Transmembrane Segment Six Is Altered during the Catalytic Cycle of P-glycoprotein* , 2004, Journal of Biological Chemistry.

[50]  I. Pastan,et al.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. , 1986, Science.

[51]  A. Davidson,et al.  The Maltose Transport System of Escherichia coli Displays Positive Cooperativity in ATP Hydrolysis (*) , 1996, The Journal of Biological Chemistry.

[52]  Jue Chen,et al.  ATP-binding cassette transporters in bacteria. , 2004, Annual review of biochemistry.

[53]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[54]  Lutz Schmitt,et al.  Structure and mechanism of ABC transporters. , 2002, Current opinion in structural biology.

[55]  Paola Vergani,et al.  The ABC protein turned chloride channel whose failure causes cystic fibrosis , 2006, Nature.

[56]  J. Riordan,et al.  Purification and Crystallization of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)* , 2004, Journal of Biological Chemistry.

[57]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[58]  R. Callaghan,et al.  The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models , 2003, British Journal of Cancer.

[59]  F. Sharom,et al.  Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. , 2000, Biochemistry.

[60]  P. Gros,et al.  Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity. , 2000, Biochemistry.

[61]  N. Karnani,et al.  Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis. , 2003, Biochemistry.

[62]  C. Higgins,et al.  The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein , 1999, British journal of pharmacology.

[63]  M. Yamazaki,et al.  Clinical Relevance of P-Glycoprotein in Drug Therapy , 2003, Drug metabolism reviews.

[64]  P. Gros,et al.  Overexpression, purification, and functional characterization of ATP-binding cassette transporters in the yeast, Pichia pastoris. , 2003, Biochimica et biophysica acta.

[65]  W. Wahli,et al.  Regional variations in ABC transporter expression along the mouse intestinal tract. , 2004, Physiological genomics.

[66]  D. Housman,et al.  The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues , 1989, Molecular and cellular biology.

[67]  Anastassis Perrakis,et al.  The crystal structure of DNA mismatch repair protein MutS binding to a G·T mismatch , 2000, Nature.

[68]  C. Higgins,et al.  The multi‐drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P‐glycoprotein by an allosteric interaction , 1997, British journal of pharmacology.

[69]  I. Holland,et al.  ABC transporters: bacterial exporters-revisited five years on. , 1999, Biochimica et biophysica acta.

[70]  P. Melera,et al.  Mutations in the sixth transmembrane domain of P-glycoprotein that alter the pattern of cross-resistance also alter sensitivity to cyclosporin A reversal. , 1997, Molecular pharmacology.

[71]  D. Keppler,et al.  Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.

[72]  C. Higgins,et al.  The homodimeric ATP‐binding cassette transporter LmrA mediates multidrug transport by an alternating two‐site (two‐cylinder engine) mechanism , 2000, The EMBO journal.

[73]  D. Keppler,et al.  ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. , 1994, Cancer research.

[74]  M. Putman,et al.  Structure-function analysis of multidrug transporters in Lactococcus lactis. , 1999, Biochimica et biophysica acta.

[75]  T. Amachi,et al.  Non-equivalent cooperation between the two nucleotide-binding folds of P-glycoprotein. , 1998, Biochimica et biophysica acta.

[76]  W. Konings,et al.  The ABC family of multidrug transporters in microorganisms. , 1998, Biochimica et biophysica acta.

[77]  Yue Weng,et al.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.

[78]  A. Seelig.  A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[79]  D. Clarke,et al.  Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site* , 2003, Journal of Biological Chemistry.

[80]  D. Clarke,et al.  Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Welsh,et al.  The Two Nucleotide-binding Domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Have Distinct Functions in Controlling Channel Activity (*) , 1995, The Journal of Biological Chemistry.

[82]  M. Azzaria,et al.  Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance , 1989, Molecular and cellular biology.

[83]  Geoffrey Chang,et al.  Retraction of "Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation" [J. Mol. Biol. (2003) 330 419-430]. , 2007, Journal of molecular biology.

[84]  I. Paulsen,et al.  Proton-dependent multidrug efflux systems , 1996, Microbiological reviews.

[85]  D. Gingras,et al.  P‐glycoprotein is localized in caveolae in resistant cells and in brain capillaries , 2000, FEBS letters.

[86]  A. Walmsley,et al.  The structure and function of drug pumps: an update. , 2003, Trends in microbiology.

[87]  I. Roninson,et al.  P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation. , 2001, Biochemistry.

[88]  J. Riordan,et al.  The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover* , 2002, The Journal of Biological Chemistry.

[89]  W Vaalburg,et al.  A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier. , 1999, Cancer research.

[90]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[91]  R. Kölling,et al.  Functional asymmetry of the two nucleotide binding domains in the ABC transporter Ste6 , 2001, Molecular Genetics and Genomics.

[92]  Andrei Aleksandrov,et al.  Domain interdependence in the biosynthetic assembly of CFTR. , 2007, Journal of molecular biology.

[93]  P. Gros,et al.  Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and Immunofluorescence (*) , 1996, The Journal of Biological Chemistry.

[94]  Z. Fuks,et al.  Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. , 1984, Cancer research.

[95]  Li-Wei Hung,et al.  Crystal structure of the ATP-binding subunit of an ABC transporter , 1998, Nature.

[96]  R. Bergmann,et al.  Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells , 1998, Journal of neurochemistry.

[97]  R. Béliveau,et al.  Identification of the cyclosporin-binding site in P-glycoprotein. , 1998, Biochemistry.

[98]  I. Roninson,et al.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.

[99]  H L Pearce,et al.  Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[100]  P Chiba,et al.  Interaction field based and hologram based QSAR analysis of propafenone-type modulators of multidrug resistance. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

[101]  S. Cole,et al.  Comparison of the Functional Characteristics of the Nucleotide Binding Domains of Multidrug Resistance Protein 1* , 2000, The Journal of Biological Chemistry.

[102]  H. Lage.  ABC-transporters: implications on drug resistance from microorganisms to human cancers. , 2003, International journal of antimicrobial agents.

[103]  Wei Yang,et al.  Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA , 2000, Nature.

[104]  D. Ferry,et al.  P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site. , 1992, Biochemical and biophysical research communications.

[105]  D. Clarke,et al.  Simultaneous Binding of Two Different Drugs in the Binding Pocket of the Human Multidrug Resistance P-glycoprotein* , 2003, Journal of Biological Chemistry.

[106]  D. Clarke,et al.  Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane* , 2000, The Journal of Biological Chemistry.

[107]  D. Housman,et al.  Cloning and characterization of a second member of the mouse mdr gene family , 1988, Molecular and cellular biology.

[108]  A. E. Senior,et al.  Conserved Walker A Ser Residues in the Catalytic Sites of P-glycoprotein Are Critical for Catalysis and Involved Primarily at the Transition State Step* , 2000, The Journal of Biological Chemistry.

[109]  J. Riordan,et al.  The cystic fibrosis transmembrane conductance regulator. , 1993, Annual review of physiology.

[110]  K. Linton,et al.  Detailed characterization of cysteine‐less P‐glycoprotein reveals subtle pharmacological differences in function from wild‐type protein , 2001, British journal of pharmacology.

[111]  A. E. Senior,et al.  Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. , 1993, The Journal of biological chemistry.

[112]  I. Pastan,et al.  Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[113]  D. Rees,et al.  The High-Affinity E. coli Methionine ABC Transporter: Structure and Allosteric Regulation , 2008, Science.

[114]  K. Linton,et al.  The Escherichia coli ATP‐binding cassette (ABC) proteins , 1998, Molecular microbiology.

[115]  J. Koeller,et al.  Phase I study of vinblastine and verapamil given by concurrent iv infusion. , 1985, Cancer treatment reports.

[116]  I. Pastan,et al.  The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. , 1987, The Journal of biological chemistry.

[117]  C. Higgins,et al.  Three-dimensional Structure of P-glycoprotein , 2005, Journal of Biological Chemistry.

[118]  Olaf van Tellingen,et al.  The importance of drug-transporting P-glycoproteins in toxicology. , 2001 .

[119]  P. Sonneveld,et al.  Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95) , 2006, Cancer.

[120]  D. Housman,et al.  Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells , 1984, Nature.

[121]  E. Matera,et al.  Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein. , 2006, Bioorganic & medicinal chemistry.

[122]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[123]  H L Pearce,et al.  Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. , 1988, Molecular pharmacology.

[124]  I. Pastan,et al.  Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene , 1986, Molecular and cellular biology.

[125]  D. Clarke,et al.  Drug Binding in Human P-glycoprotein Causes Conformational Changes in Both Nucleotide-binding Domains* , 2003, The Journal of Biological Chemistry.

[126]  I. Tamai,et al.  Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. , 1991, The Journal of biological chemistry.

[127]  Lakshmi P Kotra,et al.  A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators. , 2006, Journal of medicinal chemistry.

[128]  Rachelle Gaudet,et al.  Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing , 2001, The EMBO journal.

[129]  A. Safa,et al.  Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine. , 1989, Biochemical and biophysical research communications.

[130]  J. Verweij,et al.  Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[131]  Z. Sauna,et al.  Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[132]  I. Roninson,et al.  Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity. , 2001, Biochemistry.

[133]  Y. Assaraf,et al.  The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and Its Modulation* , 1996, The Journal of Biological Chemistry.

[134]  D. Rees,et al.  An Inward-Facing Conformation of a Putative Metal-Chelate-Type ABC Transporter , 2007, Science.

[135]  D. Clarke,et al.  Identification of Residues in the Drug-binding Domain of Human P-glycoprotein , 1999, The Journal of Biological Chemistry.

[136]  P. Melera,et al.  Transmembrane domain (TM) 9 represents a novel site in P-glycoprotein that affects drug resistance and cooperates with TM6 to mediate [125I]iodoarylazidoprazosin labeling. , 2001, Molecular pharmacology.

[137]  Z. Sauna,et al.  Evidence for the Vectorial Nature of Drug (Substrate)-stimulated ATP Hydrolysis by Human P-glycoprotein* 210 , 2001, The Journal of Biological Chemistry.

[138]  I. Holland,et al.  ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. , 1999, Journal of molecular biology.

[139]  C. Vergely,et al.  In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. , 1993, Cancer research.

[140]  L. Greenberger,et al.  Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. , 1993, The Journal of biological chemistry.

[141]  I. Pastan,et al.  Both ATP sites of human P-glycoprotein are essential but not symmetric. , 1999, Biochemistry.

[142]  D. Kerr,et al.  Phase I and pharmacokinetic study of D-verapamil and doxorubicin. , 1991, British journal of cancer.

[143]  C. Higgins,et al.  Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.

[144]  D. Clarke,et al.  The “LSGGQ” Motif in Each Nucleotide-binding Domain of Human P-glycoprotein Is Adjacent to the Opposing Walker A Sequence* , 2002, The Journal of Biological Chemistry.

[145]  J. Riordan,et al.  Crystallographic and single-particle analyses of native- and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. , 2005, Biochemical Society transactions.

[146]  J. M. Sauder,et al.  Structure of nucleotide‐binding domain 1 of the cystic fibrosis transmembrane conductance regulator , 2004, The EMBO journal.

[147]  L. Greenberger,et al.  Functional Evidence That Transmembrane 12 and the Loop between Transmembrane 11 and 12 Form Part of the Drug-binding Domain in P-glycoprotein Encoded by MDR1 (*) , 1995, The Journal of Biological Chemistry.

[148]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[149]  D. Clarke,et al.  Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoprotein , 2003, The Journal of Biological Chemistry.

[150]  C. Seynaeve,et al.  A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance. , 1991, British Journal of Cancer.

[151]  J. Bowie,et al.  Bicelle crystallization: a new method for crystallizing membrane proteins yields a monomeric bacteriorhodopsin structure. , 2002, Journal of molecular biology.

[152]  John F Hunt,et al.  Cooperative, ATP-dependent Association of the Nucleotide Binding Cassettes during the Catalytic Cycle of ATP-binding Cassette Transporters* , 2002, The Journal of Biological Chemistry.

[153]  P. Gros,et al.  Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins. , 1993, Biochemistry.

[154]  Geoffrey Chang,et al.  Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. , 2003, Journal of molecular biology.

[155]  S. Kaye,et al.  The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. , 1990, Biochemical pharmacology.

[156]  D. Clarke,et al.  The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium. , 2004, Biochemistry.

[157]  D. Housman,et al.  Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[158]  Stephan Kopp,et al.  P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling Approach , 2005, Molecular Pharmacology.

[159]  S. Kane,et al.  Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. , 1997, Biochemistry.

[160]  A. Nairn,et al.  Distinct Mg2+-dependent Steps Rate Limit Opening and Closing of a Single CFTR Cl− Channel , 2002, The Journal of general physiology.

[161]  G. Tusnády,et al.  Membrane topology distinguishes a subfamily of the ATP‐binding cassette (ABC) transporters , 1997, FEBS letters.

[162]  R. Johnson,et al.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. , 1979, Cancer research.

[163]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[164]  D D Breimer,et al.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.

[165]  D. Clarke,et al.  Determining the Dimensions of the Drug-binding Domain of Human P-glycoprotein Using Thiol Cross-linking Compounds as Molecular Rulers* , 2001, The Journal of Biological Chemistry.

[166]  R. W. Brockman,et al.  MECHANISMS OF RESISTANCE TO ANTICANCER AGENTS. , 1963, Advances in cancer research.

[167]  C. Higgins,et al.  Multiple molecular mechanisms for multidrug resistance transporters , 2007, Nature.

[168]  L. Schmitt,et al.  Crystal structure of the nucleotide-binding domain of the ABC-transporter haemolysin B: identification of a variable region within ABC helical domains. , 2003, Journal of molecular biology.

[169]  S. Cole,et al.  Characterization of Binding of Leukotriene C4 by Human Multidrug Resistance Protein 1 , 2001, The Journal of Biological Chemistry.

[170]  C. B. Roth,et al.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. , 2001, Science.

[171]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[172]  Colin Hughes,et al.  Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export , 2000, Nature.

[173]  Jue Chen,et al.  Alternating access in maltose transporter mediated by rigid-body rotations. , 2009, Molecular cell.

[174]  T. Kwan,et al.  Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning. , 1996, Biochemistry.

[175]  I. Roninson,et al.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene , 1988, Cell.

[176]  Y. Assaraf,et al.  Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. , 1997, European journal of biochemistry.

[177]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[178]  D. Clarke,et al.  Covalent Modification of Human P-glycoprotein Mutants Containing a Single Cysteine in Either Nucleotide-binding Fold Abolishes Drug-stimulated ATPase Activity (*) , 1995, The Journal of Biological Chemistry.

[179]  G. Chang,et al.  Structure of the ABC Transporter MsbA in Complex with ADP·Vanadate and Lipopolysaccharide , 2005, Science.

[180]  R. Callaghan,et al.  The translocation mechanism of P‐glycoprotein , 2006, FEBS letters.

[181]  K. Locher,et al.  Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.

[182]  K. Linton,et al.  An atomic detail model for the human ATP binding cassette transporter P‐glycoprotein derived from disulphide cross‐ linking and homology modeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[183]  D. Clarke,et al.  Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein* , 2002, The Journal of Biological Chemistry.

[184]  A. Driessen,et al.  Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[185]  W. T. Beck,et al.  The cell biology of multiple drug resistance. , 1987, Biochemical pharmacology.

[186]  D. Kessel,et al.  Effects of L‐asparaginase on protein and glycoprotein synthesis , 1970, FEBS letters.

[187]  K. Paull,et al.  P-glycoprotein substrates and antagonists cluster into two distinct groups. , 1997, Molecular pharmacology.

[188]  Giovanna Ferro‐Luzzi Ames,et al.  Characterization of the Adenosine Triphosphatase Activity of the Periplasmic Histidine Permease, a Traffic ATPase (ABC Transporter)* , 1997, The Journal of Biological Chemistry.

[189]  R. Pincheira,et al.  Conformational changes of P-glycoprotein by nucleotide binding. , 1997, The Biochemical journal.

[190]  E Schneider,et al.  ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. , 1998, FEMS microbiology reviews.

[191]  B. Sarkadi,et al.  An inventory of the human ABC proteins. , 1999, Biochimica et biophysica acta.

[192]  F. Ashcroft,et al.  3‐D structural and functional characterization of the purified KATP channel complex Kir6.2–SUR1 , 2005, The EMBO journal.

[193]  W. Scheithauer,et al.  Phase I/II trial of dexverapamil, epirubicin, and granulocyte‐macrophage–colony stimulating factor in patients with advanced pancreatic adenocarcinoma , 1995 .

[194]  Gabriele Cruciani,et al.  A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. , 2005, Journal of medicinal chemistry.

[195]  C. Vigano,et al.  Ligand-mediated Tertiary Structure Changes of Reconstituted P-glycoprotein , 1999, The Journal of Biological Chemistry.

[196]  A. di Pietro,et al.  Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis. , 2002, Journal of molecular biology.

[197]  D. Clarke,et al.  Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. , 2006, The Biochemical journal.

[198]  J. Au,et al.  Interdependent Effect of P-Glycoprotein-Mediated Drug Efflux and Intracellular Drug Binding on Intracellular Paclitaxel Pharmacokinetics: Application of Computational Modeling , 2003, Journal of Pharmacology and Experimental Therapeutics.

[199]  Satoshi Murakami,et al.  Crystal structure of bacterial multidrug efflux transporter AcrB , 2002, Nature.

[200]  G. Giaccone,et al.  A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[201]  R. Tampé,et al.  Structural and Functional Fingerprint of the Mitochondrial ATP-binding Cassette Transporter Mdl1 from Saccharomyces cerevisiae* , 2006, Journal of Biological Chemistry.

[202]  C. Vigano,et al.  Structural and Functional Asymmetry of the Nucleotide-binding Domains of P-glycoprotein Investigated by Attenuated Total Reflection Fourier Transform Infrared Spectroscopy* , 2002, The Journal of Biological Chemistry.

[203]  K. Skorecki,et al.  Reduced cyclosporin accumulation in multidrug-resistant cells. , 1988, Biochemical and biophysical research communications.

[204]  R. Johnson,et al.  Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia. , 1977, Cancer research.

[205]  Z. Sauna,et al.  Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoprotein , 2001, The Journal of Biological Chemistry.

[206]  Peter Nollert,et al.  Crystallization of membrane proteins in cubo. , 2002, Methods in enzymology.

[207]  I. Kerr.  Structure and association of ATP-binding cassette transporter nucleotide-binding domains. , 2002, Biochimica et biophysica acta.

[208]  C. Higgins,et al.  Communication between multiple drug binding sites on P-glycoprotein. , 2000, Molecular pharmacology.

[209]  V. Ling,et al.  Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. , 2001, European journal of biochemistry.

[210]  A. Schinkel,et al.  The physiological function of drug-transporting P-glycoproteins. , 1997, Seminars in cancer biology.

[211]  P. van Endert,et al.  Distinct Functions of the ATP Binding Cassettes of Transporters Associated with Antigen Processing , 2001, The Journal of Biological Chemistry.

[212]  T. Fojo,et al.  Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[213]  D. Clarke,et al.  Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil* , 2001, The Journal of Biological Chemistry.

[214]  R. Ganapathi,et al.  Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. , 1983, Cancer research.

[215]  H. Glossmann,et al.  Resolving the structure of the Ca2+ channel by photoaffinity labelling , 1987 .

[216]  R. Tampé,et al.  A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer , 1996, Nature Genetics.

[217]  John A. Tainer,et al.  Structural Biology of Rad50 ATPase ATP-Driven Conformational Control in DNA Double-Strand Break Repair and the ABC-ATPase Superfamily , 2000, Cell.

[218]  Z. Sauna,et al.  Functionally Similar Vanadate-induced 8-Azidoadenosine 5′-[α-32P]Diphosphate-trapped Transition State Intermediates of Human P-glycoprotein Are Generated in the Absence and Presence of ATP Hydrolysis* , 2001, The Journal of Biological Chemistry.

[219]  Z. Sauna,et al.  Characterization of the Catalytic Cycle of ATP Hydrolysis by Human P-glycoprotein , 2001, The Journal of Biological Chemistry.

[220]  B. Dijkstra,et al.  Crystal structures of the ATPase subunit of the glucose ABC transporter from Sulfolobus solfataricus: nucleotide-free and nucleotide-bound conformations. , 2003, Journal of molecular biology.

[221]  K. Locher,et al.  ABC transporter architecture and mechanism: implications from the crystal structures of BtuCD and BtuF , 2004, FEBS letters.

[222]  E. Goormaghtigh,et al.  Secondary and Tertiary Structure Changes of Reconstituted P-glycoprotein , 1996, The Journal of Biological Chemistry.

[223]  E. Balzi,et al.  Antibiotic efflux pumps. , 2000, Biochemical pharmacology.

[224]  B. Sikic,et al.  Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[225]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[226]  W. T. Beck,et al.  Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. , 1998, Biochemical pharmacology.

[227]  W. T. Beck.  Multidrug resistance and its circumvention. , 1990, European journal of cancer.

[228]  I. Pastan,et al.  Characterization of the azidopine and vinblastine binding site of P-glycoprotein. , 1992, The Journal of biological chemistry.

[229]  D. Clarke,et al.  Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate* , 1997, The Journal of Biological Chemistry.

[230]  N. Bleehen,et al.  Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[231]  M. Welsh,et al.  Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. , 1992, Science.

[232]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[233]  R. Allikmets,et al.  Evolution of ATP-binding cassette transporter genes. , 1995, Current opinion in genetics & development.

[234]  S. Cole,et al.  Identification and Characterization of Functionally Important Elements in the Multidrug Resistance Protein 1 COOH-terminal Region* , 2004, Journal of Biological Chemistry.

[235]  I. Pastan,et al.  ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[236]  Remigijus Didziapetris,et al.  Classification Analysis of P-Glycoprotein Substrate Specificity , 2003, Journal of drug targeting.

[237]  R. Callaghan,et al.  Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2. , 2006, Structure.

[238]  F. Quiocho,et al.  Crystal structure of a catalytic intermediate of the maltose transporter , 2007, Nature.